In brief
Nature 448, 121 (2007). doi:10.1038/448121a
Brazil dealAbbott Laboratories, the Illinois-based drug company, reached agreement with the Brazilian government to sell its AIDS drug Kaletra there for a reduced price #8212; lifting the threat that Brazil might license it compulsorily. On 4 July, the company said it would sell it (Source: Nature)div id=medwormpbiMedWorm Message:/i/b Find the best a href=http://www.januarysales.org/ target=_blankJanuary Sales/a in the UK./p/div
Abbott Receives FDA Approval For Lower-Dose Of Antiretroviral Kaletra For Children
Abbott Laboratories on Monday announced that it has received FDA approval to market and sell a lower-dose version of its antiretroviral drug Kaletra for children, the Chicago Sun-Times reports (Knowles, Chicago Sun-Times, 11/13). The tablet will be available in the U.S. this month, Bloomberg/Chicago Tribune reports. [click link for full article] (Source: Health News from Medical News Today)
